Netherlands· NL-2606cf209a30

Enzalutamide CF 40 mg, filmomhulde tabletten

A enzalutamide product containing enzalutamide, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC L02BB04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about enzalutamideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Enzalutamide is registered in 16 of 19 countries.

Countries holding a registration under ATC L02BB04 (enzalutamide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search enzalutamide products by name

Enzalutamide · ATC L02BB04

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of enzalutamide costs, country by country.

Normalised to the WHO defined daily dose (0.16 g), the median price runs from $0.46 in France to $135.12 in Switzerland — a ×295 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Enzalutamide · price per daily dose (0.16 g)

USD · FX 28 Sept 2026

CH Switzerland$135.12
FR France$0.46

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ENZALUTAMIDE
Manufacturer: Centrafarm B.V.
Country: Netherlands (NL)
ATC code: L02BB04
ATC class: Enzalutamide
Defined daily dose: 0.16 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
131695

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

706 interactions on record for enzalutamide.

Graded by severity as the source publishes them — 241 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check enzalutamide against other medicines How interaction checks work

Enzalutamide · interactions on record

706 records

241 severe
448 moderate
17 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
RolapitantA04AD14severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Enzalutamide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All enzalutamide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Englabloc, Enzalutamid 1a Pharma
Belgium · Enzalutamide Accord, Enzalutamide Eg
Bulgaria · Ензалутамид Sdz, Ензалутамид Сандоз
Cyprus · Enzalutamide Accord, Enzalutamide Ebewe
Czechia · Enzalutamid Sandoz S.R.O., Enzalutamid Stada
Germany · Enzalutamid Accord, Enzalutamid Al
Denmark · Enzalutamide "sandoz", Enzalutamide Hexal
Estonia · Enzalutamide Accord, Enzalutamide Norameda
Spain · Enzalutamida Accord, Enzalutamida Sandoz
Finland · Enzalutamide 1a Farma, Enzalutamide Adalvo
France · Enzalutamide Accord, Enzalutamide Biogaran
United Kingdom (Northern Ireland) · Enzalutamide Accord Healthcare, Enzalutamide Genus Pharmaceuticals
Greece · Enzalutamide Accord, Enzalutamide Anabiosis
Croatia · Enzalutamid Accord, Enzalutamid Pharmascience
Hungary · Enzalutamid 1 A Pharma, Enzalutamid Sandoz
Ireland · Enzalutamide Accord, Enzalutamide Clonmel
Iceland · Enzalutamide Accordpharma, Enzalutamide Hexal
Italy · Enzalutamide Accord, Enzalutamide Eg
Liechtenstein · Enzalutamide Accordpharma, Enzalutamide Viatris
Lithuania · Enzalutamide Accord, Enzalutamide Hexal
Luxembourg · Enzalutamide Eg
Latvia · Enzalutamide Accord, Enzalutamide Hexal
Malta · Enzalutamid Pharos, Enzalutamide
Norway · Enzalutamide Accord, Enzalutamide Accordpharma
Poland · Enzalutamid Sandoz, Enzalutamide
Portugal · Enzalutamida Stada, Enzalutamida Stada 40 Mg Comprimidos Revestidos Por Película
Romania · Enzalutamidă Accord, Enzalutamida Rhei
Sweden · Enzalutamid Sun Pharma, Enzalutamide Hexal
Slovenia · Enzalutamid Sandoz, Enzalutamid Sandoz Gmbh
Slovakia · Englabloc, Enzalutamid Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d8ac8da4-78a3-4750-b33b-d344d9bdfd97
GET /v1/drugs/d8ac8da4-78a3-4750-b33b-d344d9bdfd97?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131695_smpc.pdf",
  "strength": null,
  "atc_label": "Enzalutamide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131695",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "MACROGOL",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ENZALUTAMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131695.pdf",
  "authorised_at": "2024/06/17",
  "procedure_number": "NL/H/5871/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131695",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about enzalutamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console